Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
1.435
+0.035 (2.50%)
Nov 21, 2024, 12:08 PM EST - Market open

Salarius Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
2.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 20211.84M-3.39M-64.84%
Dec 31, 20205.23M1.77M51.03%
Dec 31, 20193.47M1.51M77.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xylo Technologies 57.64M
Scorpius Holdings 10.04M
Akanda 2.51M
Biodexa Pharmaceuticals 104.90K
Sonnet BioTherapeutics Holdings 55.88K
Revenue Rankings